ArticleFrontiers in surgery2026
Case Report: Adult liver transplantation using a long-standing mesocaval shunt as portal inflow in congenital absence of the portal vein with atypical variceal bleeding and refractory shunt encephalopathy.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital absence of the portal vein (CAPV) is an exceedingly rare vascular malformation in which mesenteric and splenic venous blood bypasses the liver and drains into the systemic circulation. Because congenital portosystemic drainage usually decompresses the splanchnic venous bed, classical portal hypertension is uncommon, and CAPV typically presents with metabolic and vascular complications rather than variceal bleeding. We report the case of a 36-year-old woman with CAPV that presented atypically in early childhood with esophageal variceal hemorrhage, suggesting functional inadequacy or early loss of the native decompressive pathway. At the age of three years, she underwent H-type mesocaval shunting and remained clinically compensated for more than three decades. She later developed refractory shunt-related hyperammonemic encephalopathy with recurrent functional bowel obstruction, without evidence of mechanical obstruction on repeated imaging and laparotomy. Orthotopic liver transplantation was performed using a graft from a brain-dead donor. Because the native portal vein was absent, portal inflow was reconstructed by an end-to-end shunt-to-portal anastomosis using the long-standing mesocaval shunt, avoiding the need for an interposition venous graft. The postoperative course was complicated by a biliary anastomotic stricture managed with staged endoscopic stenting and by late stenosis of the shunt-to-portal anastomosis on postoperative day 212, successfully treated with balloon angioplasty and portal vein stenting. At the 275-day follow-up, the patient remained clinically stable, with no recurrence of encephalopathy and resolution of intestinal dysmotility. This case highlights a rare adult presentation of CAPV requiring liver transplantation and demonstrates that a long-standing mesocaval shunt may serve as a feasible source of portal inflow when the native portal vein is absent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.